Nicol Kurstjens

472 total citations
18 papers, 379 citations indexed

About

Nicol Kurstjens is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Transplantation. According to data from OpenAlex, Nicol Kurstjens has authored 18 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 4 papers in Molecular Biology and 4 papers in Transplantation. Recurrent topics in Nicol Kurstjens's work include Blood Pressure and Hypertension Studies (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Cardiac Health and Mental Health (3 papers). Nicol Kurstjens is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Renal Transplantation Outcomes and Treatments (4 papers) and Cardiac Health and Mental Health (3 papers). Nicol Kurstjens collaborates with scholars based in Australia, Germany and New Zealand. Nicol Kurstjens's co-authors include Caroline M. Markey, Robyn H. Guymer, Jennifer Arnold, R.C. Cantrill, Garry Jennings, Peter Bremner, M. Carrington, Philip J. Thompson, J. Patton and Bruce Davidson and has published in prestigious journals such as Biochemical and Biophysical Research Communications, BMJ and European Journal of Biochemistry.

In The Last Decade

Nicol Kurstjens

18 papers receiving 367 citations

Peers

Countries citing papers authored by Nicol Kurstjens

Since Specialization

Citations

This map shows the geographic impact of Nicol Kurstjens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicol Kurstjens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicol Kurstjens more than expected).

Fields of papers citing papers by Nicol Kurstjens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicol Kurstjens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicol Kurstjens. The network helps show where Nicol Kurstjens may publish in the future.

Co-authorship network of co-authors of Nicol Kurstjens

This figure shows the co-authorship network connecting the top 25 collaborators of Nicol Kurstjens. A scholar is included among the top collaborators of Nicol Kurstjens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicol Kurstjens. Nicol Kurstjens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Everolimus Plus Reduced-Exposure Cyclosporin versus Mycophenolic Acid Plus Cyclosporin: Seven-Year Follow-Up of Australia and New Zealand Kidney Transplant Recipients in the A2309 Study. 2016 ·American Journal of Transplantation ·Steven J. Chadban, Helen Pilmore, Graeme R. Russ, John Kanellis, S. Campbell, (unknown), Wendy Lim, (unknown), Nicol Kurstjens, (unknown)	3
2	The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study 2016 ·BMC Ophthalmology ·Jennifer Arnold, Caroline M. Markey, Nicol Kurstjens, Robyn H. Guymer	74
3	BASELINE CHARACTERISTICS OF THE FLUID STUDY PATIENTS: A RANDOMISED CLINICAL TRIAL INVESTIGATING THE NEED FOR COMPLETE RESOLUTION OF SUB-RETINAL FLUID (SRF) IN RANIBIZUMAB-TREATED PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) USING A TREAT AND EXTEND (T&E) REGIMEN 2015 ·Clinical and Experimental Ophthalmology ·Jennifer Arnold, Caroline M. Markey, Paul N. Baird, Andrea J. Richardson, Nicol Kurstjens, Robyn H. Guymer	1
4	Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study—a randomised controlled trial 2015 ·Thorax ·Peter Frith, Philip J. Thompson, Rajeev Ratnavadivel, Catherina L. Chang, Peter Bremner, (unknown), (unknown), Nicol Kurstjens, (unknown)	67
5	Impact of nurse-mediated management on achieving blood pressure goal levels in primary care: Insights from the Valsartan Intensified Primary carE Reduction of Blood Pressure Study 2015 ·European Journal of Cardiovascular Nursing ·M. Carrington, Garry Jennings, Mark Harris, Mark Nelson, Markus P. Schlaich, Nigel Stocks, Louise M. Burrell, John Amerena, Ferdinandus J. de Looze, (unknown), Nicol Kurstjens, Simon Stewart, (unknown)	8
6	Late-breaking abstract: Glycopyrronium once-daily significantly improves lung function and health status when added to fluticasone/salmeterol in patients with COPD: The GLISTEN study 2014 ·European Respiratory Journal ·Peter Frith, Rajeev Ratnavadivel, Philip J. Thompson, Peter Bremner, Catherina L. Chang, (unknown), (unknown), Nicol Kurstjens, (unknown)	2
7	More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care 2014 ·Journal of Hypertension ·Simon Stewart, Nigel Stocks, Louise M. Burrell, Ferdinandus J. de Looze, Adrian Esterman, Mark Harris, Joseph Hung, (unknown), Nicol Kurstjens, Garry Jennings, M. Carrington	7
8	A randomized, controlled trial of everolimus‐based dual immunosuppression versus standard of care in de novo kidney transplant recipients 2013 ·Transplant International ·Steven J. Chadban, Josette Eris, John Kanellis, Helen Pilmore, (unknown), Soo Kun Lim, (unknown), Nicol Kurstjens, Graeme R. Russ, (unknown)	41
9	Determinants of Achieving Early Blood Pressure Control with Monotherapy in a Primary Care Setting 2013 ·Journal of Clinical Hypertension ·Simon Stewart, M. Carrington, (unknown), Nicol Kurstjens, Alex Brown, Louise M. Burrell, Mark Nelson, Nigel Stocks, Garry Jennings, (unknown)	3
10	Effect of intensive structured care on individual blood pressure targets in primary care: multicentre randomised controlled trial 2012 ·BMJ ·Simon Stewart, M. Carrington, (unknown), Craig S. Anderson, Nicol Kurstjens, John Amerena, Alex Brown, Louise M. Burrell, Ferdinandus J. de Looze, Mark Harris, Joseph Hung, Henry Krum, Mark Nelson, Markus P. Schlaich, Nigel Stocks, Garry Jennings, (unknown)	87
11	Conversion to enteric‐coated mycophenolate sodium from mycophenolate mofetil in stable renal transplant patients: Results of an Asia–Pacific study 2012 ·Nephrology ·Po‐Huang Lee, Anantharaman Vathsala, Duck Jong Han, Tak Mao Chan, H.S. Wong, (unknown), Nicol Kurstjens, (unknown), (unknown), Sheng‐Hsien Chu, (unknown), (unknown), Wen‐Jeng Lee, Jong‐Da Lian, Wu‐Chang Yang, Zaki Morad, (unknown), (unknown), (unknown), (unknown)	4
12	Enteric‐coated mycophenolate sodium in combination with full dose or reduced dose cyclosporine, basiliximab and corticosteroids in Australian de novo kidney transplant patients 2012 ·Nephrology ·Steven J. Chadban, Josette Eris, Graeme R. Russ, Scott B. Campbell, Jeremy R. Chapman, Bruce A. Pussell, Paul Trevillian, Francesco L. Ierino, Napier M. Thomson, Brian Hutchison, Ashley Irish, (unknown), Nicol Kurstjens, Rowan G. Walker, (unknown)	5
13	Optimising management of hypertension in primary care: The Valsartan Intensified Primary Care Reduction of Blood Pressure (Viper-Bp) Study 2011 ·International Journal of Cardiology ·Simon Stewart, M. Carrington, (unknown), Nicol Kurstjens, Garry Jennings	9
14	Binding of α‐ and βγ‐subunits of G₀ to β₁‐adrenoceptor in sealed unilamellar lipid vesicles 1991 ·European Journal of Biochemistry ·Nicol Kurstjens, (unknown), Christian Dees, R.C. Cantrill, Mirko Hekman, Ernst Helmreich	19
15	Multiple hormone actions: The rises in cAMP and Ca ++ in mdck-cells treated with glucagon and prostaglandin E 1 are independent processes 1990 ·Biochemical and Biophysical Research Communications ·Nicol Kurstjens, (unknown), R.C. Cantrill, Matthias Hahn, Fritz Boege	13
16	Systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine reduces the release of [3H]dopamine from rat striatal slices 1989 ·European Journal of Pharmacology ·Nicol Kurstjens, R.C. Cantrill	2
17	Proteolytic degradation routes for turkey β1-adrenoceptor probed with antipeptide antibodies against the N-terminal sequence of the receptor 1989 ·Biochemical and Biophysical Research Communications ·(unknown), Gerald Münch, Fritz Boege, R.C. Cantrill, Nicol Kurstjens	4
18	Essential fatty acids modulate apomorphine activity at dopamine receptors in cat caudate slices 1988 ·European Journal of Pharmacology ·Bruce Davidson, Nicol Kurstjens, J. Patton, R.C. Cantrill	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact